Focal therapies are new options for the treatment of localized prostate cancer.
Vascular-targeted photodynamic therapy (VTP) with WST11 is one of these options. The aim of this treatment is to destroy a targeted area of the prostate by the associated action of the WST11 drug, light exposure and oxygen. The procedure is performed under general anesthesia. Fibers are introduced trans-perineally in the prostate by ultrasound guidance. The injection of WST11 is then performed with light illumination of the specific targeted area. Current data report 83% negative biopsies 6 months after treatment with good tolerance of the treatment. However, VTP still needs to be evaluated.
Lebdai S, Martin F, Bigot P, Azzouzi AR. Are you the author?
Service d'urologie, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.
Reference: Prog Urol. 2014 Sep 3. pii: S1166-7087(14)00212-7.
Article in French.